Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,126.06
(
1.20%
)
US TECH 100
25,958.80
(
1.33%
)
Dow Jones
49,447.43
(
1.88%
)
Brent Oil
91.37
(
-1.39%
)
Bitcoin
74,651.99
(
1.07%
)
News Focus
News Focus
Post# of 21574
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

InTheTrenches

Send PM Follow Ignore
Followers 4
Posts 929
Boards Moderated 0
Alias Born 08/15/2006

InTheTrenches

Re: XenaLives post# 13532

Friday, 08/16/2019 12:42:52 PM

Friday, August 16, 2019 12:42:52 PM

Post# of 21574
Nothing to do with the drug, but it has everything to do with how the company treats it's shareholders:

According to SEC filings, almost $20M in total compensation to ONE individual, the CEO of AVXL, using cash and options issued from the company (over the past 4 years).

No transaction with other individuals noted in the filings.

Obscene precision dilution by AVXL.

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent TAOX News
More TAOX News